Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd
WARNING LETTER
•Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd

Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd – FDA Warning Letter

Record Details

This FDA Warning Letter (WL: 300-12-013), dated June 14, 2012, addresses Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd. regarding violations of the Federal Food, Drug, and Cosmetic Act. The FDA's review of drug shipments and registration records revealed the company failed to register its establishment for 2011 or 2012, despite continuing to manufacture and import drugs into the U.S.

This failure to register is a prohibited act under section 301(p) of the Act (21 U.S.C. § 331(p)) and violates section 510(i)(1) (21 U.S.C. § 360(i)(1)), which requires annual electronic registration for foreign establishments. Additionally, drugs cannot be imported unless listed per 21 CFR part 207, subpart C, and manufactured at a registered establishment (21 CFR § 207.40(b)). Unregistered drugs may be refused admission under section 801(o) or 801(a)(3) as adulterated or misbranded. Failure to list drugs or update listing information, including the manufacturing establishment's registration number (21 CFR § 207.25(b)(7)), renders drugs misbranded under section

Company
Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd
Product type
Drugs
Office
Department of Health and Human Services
Person
  • Douglas Stearn
View Company Profile

ID · d2116597-731f-4862-9a4e-3b3efcebfc56

Violation Codes10
21 U.S.C. 360(i)(1)21 U.S.C. 331(p)21 CFR 20721 CFR 207.40(b)21 U.S.C. 381(o)21 U.S.C. 360(i)21 U.S.C. 381(a)(3)21 U.S.C. 352(o)21 CFR 207.30(a)21 CFR 207.25(b)(7)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Shijiazhuang Pharma. Group Zhongnuo Pharmaceuticals Co. Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.